Facial Angiofibroma

Facial Angiofibroma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Facial Angiofibromas · Angiofibroma of Face · Angiofibromas of the face
Classified under: Cardiovascular Diseases
Musculoskeletal and Connective Tissue Diseases
Neoplasms
Indicated drugs: Sirolimus

Resolves to

Vocabularies

SNOMED CT254744006UMLSC0265319

What you can answer from here — as of September 26, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

5Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Facial Angiofibroma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.